Biodesix, Inc. provided revenue guidance for the year 2023. For the year, Company expects to generate $50 to $52 million in total revenue in 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.57 USD | -0.32% | +3.29% | -14.67% |
May. 13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
May. 08 | Transcript : Biodesix, Inc., Q1 2024 Earnings Call, May 08, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.67% | 178M | |
-22.04% | 8.54B | |
+68.22% | 4.32B | |
-1.60% | 2.53B | |
-10.16% | 2.46B | |
-38.23% | 2.48B | |
-7.85% | 1.9B | |
-17.74% | 1.59B | |
-39.48% | 1.23B | |
+9.68% | 1.13B |
- Stock Market
- Equities
- BDSX Stock
- News Biodesix, Inc.
- Biodesix, Inc. Provides Revenue Guidance for the Year 2023